Brooklyn, New York, June 30, 2023 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the Global Manufacturing Execution Systems for Biotech Manufacturers Market is projected to grow at a CAGR of 10.0% from 2023 to 2028.
Manufacturing execution systems (MES) for biotech manufacturers is majorly driven by growing demand for biotech products (including pharmaceuticals, vaccines, and biologics), which led to an increase in production activities. In line with this trend, biotech manufacturers require efficient and reliable MES solutions to streamline their manufacturing processes and ensure compliance with regulatory standards to meet the demand of manufacturing.
Furthermore, the stringent regulations by the government on biotech industry will drive the adoption of MES among biotech manufacturers. Biotech manufacturers must stick to stringent quality control and traceability requirements to ensure product safety and efficacy. MES provides real-time monitoring and data management capabilities that help manufacturers to track & document the entire manufacturing process, from raw materials to final products, thus the manufacturers can stick to compliance with regulatory standards.
Browse 147 Market Data Tables and 115 Figures spread through 163 Pages and in-depth TOC on “Global Manufacturing Execution Systems for Biotech Manufacturers Market - Forecast to 2028’’
Key Market Insights
- As per the deployment mode outlook, the cloud-based segment is expected to be the largest segment in the global manufacturing execution systems for biotech manufacturers market from 2023 to 2028.
- As per the type outlook, the integrated MES segment is expected to be the largest segment in the global manufacturing execution systems for biotech manufacturers market from 2023 to 2028.
- As per the application outlook, the production and quality control segment is expected to be the largest segment in the global manufacturing execution systems for biotech manufacturers market from 2023 to 2028.
- The Asia Pacific region is analyzed to be the fastest-growing segment in the market.
- North America region will have the largest share in the market during the forecast period of 2023-2028.
- Körber AG, Siemens AG, Emerson Electric Co., Werum IT Solutions GmbH, Dassault Systèmes SE, ABB Ltd., Honeywell International Inc., Rockwell Automation, Inc., Schneider Electric SE, SAP SE, and General Electric Company, among others, are some of the key players in the global manufacturing execution systems for biotech manufacturers market.
Request for a sample copy of the report @ https://www.globalmarketestimates.com/market-report/manufacturing-execution-systems-for-biotech-manufacturers-market-4048
Deployment Mode Outlook (Revenue, USD Billion, 2023-2028)
- Cloud-based
- On Premise
Type Outlook (Revenue, USD Billion, 2023-2028)
- Standalone MES
- Integrated MES
End-User Outlook (Revenue, USD Billion, 2023-2028)
- Research and Development (R&D)
- Production and Quality Control
- Supply Chain Management
By Regional Outlook (Revenue, USD Billion, 2023-2028)
North America
- The U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Netherlands
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Thailand
- Indonesia
- Malaysia
- Singapore
- Vietnam
- Rest of APAC
Central & South America
- Brazil
- Argentina
- Chile
- Rest of CSA
Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of MEA
Contact: Yash Jain
Director - Global Accounts & Strategic Advisory
Email address: yash.jain@globalmarketestimates.com
Phone Number: +1 6026667238
Website: www.globalmarketestimates.com
